Quotes 5-day view Delayed Nasdaq
Estimated financial data (e) (USD)
Net income 2021
Net Debt 2021
P/E ratio 2021
Net income 2022
Net Debt 2022
P/E ratio 2022
Capi. / Sales 2021
Capi. / Sales 2022
Nbr of Employees
Aravive, Inc. is a clinical-stage oncology company. The Company is focused on developing transformative treatments designed to halt the progression of life-threatening diseases. Its lead product candidate, AVB-500, is an ultrahigh-affinity, decoy protein that targets the GAS6-AXL signaling pathway associated with tumor cell growth, tumor metastasis, resistance to treatment and decreased survival. The Company is...
All news about ARAVIVE, INC.
10/01 ARAVIVE : to Present New Preliminary Data from Phase 1b Trial Evaluating AVB-500 in Clear ..
10/01 Aravive, Inc. to Present New Preliminary Data from Phase 1b Trial Evaluating AVB-500 in..
09/16 Aravive to Participate in Fireside Chat at Cantor Fitzgerald Virtual Global Healthcare ..
09/10 ARAVIVE, INC. : Submission of Matters to a Vote of Security Holders, Financial Statements ..
09/01 Aravive to Participate in Fireside Chat at H.C. Wainwright 23rd Annual Global Investmen..
08/09 ARAVIVE, INC. : Regulation FD Disclosure, Other Events, Financial Statements and Exhibits ..
08/09 ARAVIVE : Announces First Patient Dosed in Phase 1b/2 Clinical Trial of AVB-500 for the Tr..
08/09 Aravive Inc Announces First Patient Dosed in Phase 1B/2 Clinical Trial of AVB-500 for t..
08/06 ARAVIVE : Piper Sandler Adjusts Aravive's Price Target to $18 From $20, Maintains Overweig..
08/05 ARAVIVE : Q2 Earnings Snapshot
08/05 ARAVIVE : Earnings Flash (ARAV) ARAVIVE Posts Q2 Revenue $3.8M
08/05 ARAVIVE : Management's Discussion and Analysis of Financial Condition and Results of Opera..
08/05 ARAVIVE, INC. : Results of Operations and Financial Condition, Financial Statements and Ex..
08/05 Aravive, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2021
08/05 ARAVIVE : Reports Second Quarter 2021 Financial Results and Provides Corporate Updates
News in other languages on ARAVIVE, INC.
- No features available -
Analyst Recommendations on ARAVIVE, INC.
Technical analysis trends ARAVIVE, INC.
Short Term Mid-Term Long Term Trends Neutral Bearish Bearish
Number of Analysts
Last Close Price
Average target price
Spread / Average Target